“Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab” (2025) Voprosy onkologii, 70(6), pp. 1096–1105. doi:10.37469/0507-3758-2024-70-6-1096-1105.